MigraineMind research summary

Sex differences in the epidemiology, clinical features, and pathophysiology of migraine

The Lancet Neurology | 2016

Review
AuthorsVetvik et al.
JournalThe Lancet Neurology
Publication year2016
PubMed ID27836433
DOI10.1016/s1474-4422(16)30293-9

Summary

Migraine affects women two to three times more than men. Women experience longer attacks and increased headache recurrence. They also report greater disability and longer recovery times. Comorbidities, such as asthma, anxiety, and depression, often accompany migraines. These conditions increase disability for both sexes. Migraine with aura is a risk factor for vascular disorders, especially in women. However, research is limited regarding men's comparative risk for these disorders. Female sex hormones significantly influence migraine risk and features, explaining observed sex differences. Genetic variance could also contribute to these differences. While migraine is often recognized in women, it is frequently underdiagnosed in men. This underdiagnosis leads to poor management for men. Additionally, fewer men participate in clinical trials, which affects treatment development. Understanding these differences is crucial for improving migraine care and outcomes for all patients. Clinical relevance: This research highlights the need for better migraine diagnosis and management in men.

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.